Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 5
Submit an article Journal homepage
665
Views
16
CrossRef citations to date
0
Altmetric
Author's View

Osteopontin, a possible modulator of cancer stem cells and their malignant niche

Guanhua Rao College of Life Sciences; Nankai University; Tianjin, China
,
Lei Du The State Key Laboratory of Biomembrane and Membrane Biotechnology; Institute of Zoology; Chinese Academy of Sciences; Beijing, China
&
Quan Chen College of Life Sciences; Nankai University; Tianjin, China; The State Key Laboratory of Biomembrane and Membrane Biotechnology; Institute of Zoology; Chinese Academy of Sciences; Beijing, ChinaCorrespondence[email protected]
Article: e24169 | Received 26 Feb 2013, Accepted 28 Feb 2013, Published online: 01 May 2013

References

  • Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006; 66:4553 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-05-3986; PMID: 16651403
  • Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39 - 51; http://dx.doi.org/10.1016/j.cell.2010.03.014; PMID: 20371344
  • Rao G, Wang H, Li B, Huang L, Xue D, Wang X, et al. Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Clin Cancer Res 2013; 19:785 - 97; PMID: 23251004
  • Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006; 16:79 - 87; http://dx.doi.org/10.1016/j.tcb.2005.12.005; PMID: 16406521
  • Johnston NI, Gunasekharan VK, Ravindranath A, O’Connell C, Johnston PG, El-Tanani MK. Osteopontin as a target for cancer therapy. Front Biosci 2008; 13:4361 - 72; http://dx.doi.org/10.2741/3009; PMID: 18508515
  • Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med 2010; 14:2037 - 44; http://dx.doi.org/10.1111/j.1582-4934.2010.01115.x; PMID: 20597997
  • Teramoto H, Castellone MD, Malek RL, Letwin N, Frank B, Gutkind JS, et al. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene 2005; 24:489 - 501; http://dx.doi.org/10.1038/sj.onc.1208209; PMID: 15516973
  • Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem 2003; 278:28593 - 606; http://dx.doi.org/10.1074/jbc.M303445200; PMID: 12771144
  • Atai NA, Bansal M, Lo C, Bosman J, Tigchelaar W, Bosch KS, et al. Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology 2011; 132:39 - 48; http://dx.doi.org/10.1111/j.1365-2567.2010.03335.x; PMID: 20722758
  • Wai PY, Guo L, Gao C, Mi Z, Guo H, Kuo PC. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. Surgery 2006; 140:132 - 40; http://dx.doi.org/10.1016/j.surg.2006.02.005; PMID: 16904962

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.